| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Dec 7, 2017 | EBS Emergent Biosolutions Inc. | Harsanyi Zsolt | Director | Sell | 7,000 | $42.47 | $297,290.00 | -15.9% | |
| Dec 7, 2017 | AVDL Avadel Pharmaceuticals Plc | Anderson Michael S | Chief Executive Officer | Buy | 5,000 | $8.86 | $44,295.00 | +2.2% | |
| Dec 7, 2017 | PRGO Perrigo Co Plc | Wesolowski John | EVP, President Rx | Sell | 450 | $83.09 | $37,390.05 | -98.0% | |
| Dec 7, 2017 | IRWD Ironwood Pharmaceuticals Inc | Hecht Peter M | Chief Executive Officer | Sell | 113,405 | $15.12 | $1,714,515.00 | -1.2% | |
| Dec 6, 2017 | ESPR Esperion Therapeutics, Inc. | Vitullo Nicole | Director | Sell | 9,326 | $53.85 | $502,205.10 | -26.5% | |
| Dec 5, 2017 | CANN Trees Corp (colorado) | Frichtel Robert Lawrence | Chief Executive Officer | Sell | 17,688 | $2.94 | $51,948.40 | -0.7% | |
| Dec 4, 2017 | IRWD Ironwood Pharmaceuticals Inc | McHugh Julie53 | Director | Sell | 1,500 | $16.45 | $24,675.00 | -1.9% | |
| Dec 4, 2017 | LLY Eli Lilly & Co | Zulueta Alfonso G | SVP &President, Lilly Int'l | Sell | 3,532 | $86.00 | $303,752.00 | -8.1% | |
| Dec 4, 2017 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 6,279 | $75.04 | $471,159.83 | -32.3% | |
| Dec 4, 2017 | IRWD Ironwood Pharmaceuticals Inc | Olanoff Lawrence S | Director | Sell | 2,000 | $16.46 | $32,921.00 | -3.0% | |
| Dec 4, 2017 | LLY Eli Lilly & Co | Mahony Susan | SVP &Pres., Lilly Oncology | Sell | 36,585 | $86.18 | $3,152,895.30 | -40.0% | |
| Dec 1, 2017 | ALKS Alkermes Plc. | Mitchell Paul J | Director | Sell | 1,000 | $51.98 | $51,980.00 | -11.1% | |
| Dec 1, 2017 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 10,000 | $72.92 | $729,182.00 | -3.5% | |
| Dec 1, 2017 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 6,226 | $19.67 | $122,465.42 | -7.4% | |
| Dec 1, 2017 | CANN Trees Corp (colorado) | Frichtel Robert Lawrence | Chief Executive Officer | Sell | 20,000 | $2.00 | $40,000.00 | -2.4% | |
| Nov 30, 2017 | AMPH Amphastar Pharmaceuticals, Inc. | Shohet Stephen B. | Director | Sell | 7,862 | $19.25 | $151,344.29 | -24.6% | |
| Nov 30, 2017 | AMRN Amarin Corp Plc\uk | Thero John F | President And CEO | Buy | 10,000 | $3.24 | $32,446.00 | +0.9% | |
| Nov 30, 2017 | ANIK Anika Therapeutics, Inc. | Hague Richard | Chief Commercial Officer | Sell | 5,250 | $54.48 | $286,020.00 | -18.2% | |
| Nov 30, 2017 | SNOA Sonoma Pharmaceuticals, Inc. | Schutz James J | Chief Executive Officer | Buy | 345 | $4.95 | $1,707.75 | +2.2% | |
| Nov 29, 2017 | SNOA Sonoma Pharmaceuticals, Inc. | Miller Robert E | Chief Financial Officer | Buy | 1,790 | $5.02 | $8,990.80 | +7.1% | |
| Nov 29, 2017 | ALKS Alkermes Plc. | Frates James M83 | SVP, Alks Inc; CFO Alks | Sell | 20,932 | $50.51 | $1,057,248.97 | -6.8% | |
| Nov 29, 2017 | SNOA Sonoma Pharmaceuticals, Inc. | Schutz James J | Chief Executive Officer | Buy | 400 | $5.03 | $2,012.00 | +2.6% | |
| Nov 29, 2017 | PRGO Perrigo Co Plc | Wesolowski John | EVP, President Rx | Sell | 388 | $87.20 | $33,834.42 | -43.3% | |
| Nov 29, 2017 | EBS Emergent Biosolutions Inc. | El-Hibri Fuad | Chairman | Sell | 47,983 | $41.88 | $2,009,324.64 | -1.5% | |
| Nov 28, 2017 | AMPH Amphastar Pharmaceuticals, Inc. | Gerst Diane G. | EVP, Qa &Regulatory Affairs | Sell | 523 | $18.15 | $9,492.76 | -1.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.